Description of Collaborative Activity: |
NCATS-funded Tissue Chip Testing Centers (TCTC) scientists will use a reference set of validation compounds vetted by pharmaceutical representatives through an NCATS partnership with the IQ Consortium and the Food and Drug Administration (FDA) and will run tests to determine functionality, reproducibility, robustness, and reliability in these organ platforms. The TCTC scientists will coordinate activities among Tissue Chip program-funded investigators and the FDA to support the progress of these chips, with the goal of getting chips to be used widely as a validated research tool and qualified for use in pre-clinical drug testing. |
